Article
Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS.
PloS one - 1 Jan 2016
Deere Jesse D, Chang W L William, Castillo Luis D, Schmidt Kim A, Kieu Hung T, Renzette Nicholas, Kowalik Timothy, Barthold Stephen W, Shacklett Barbara L, Barry Peter A, Sparger Ellen E
Abstract excerpt
Despite tremendous progress in our understanding of human immunodeficiency virus (HIV) natural history and advances in HIV treatment, there is neither an approved vaccine nor a cure for infection. Here, we describe the development and characterization of a novel replicating vaccine vector utilizing Cytomegalovirus (CMV) and a TLR5 adjuvant. After partial truncation of the central, immunodominant hypervariable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
